I did not read the Note accurately re the July 2023 closure. Realistically, the current legal arrangement can be extended (Macbank would lick their lips as the POG is only going north). The issue is the total hedging position. Given that it is very likely that the POG is going to increase, it is prudent to close as many hedged ounces as possible or alternatively to use financial instruments (options or the like) to offset the current hedging losses as much as possible. Now is a very good time to act.
I believe that if the company allocated $100m to closing some of the hedge book that it would easily obtain finance for future Capex. A small capital raise may be required but it would not be very dilutive as the future cash flows would easily support repaying a loan. In a worst case scenario the company could pull the trigger on the dividend so there is some flexibility to play with.
- Forums
- ASX - By Stock
- RRL
- McPhillamys NPV - will it go backwards from the 2017 PFS?
RRL
regis resources limited
Add to My Watchlist
2.23%
!
$4.39

McPhillamys NPV - will it go backwards from the 2017 PFS?, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.39 |
Change
-0.100(2.23%) |
Mkt cap ! $3.316B |
Open | High | Low | Value | Volume |
$4.47 | $4.53 | $4.37 | $16.81M | 3.793M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 51252 | $4.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 7201 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4000 | 4.350 |
4 | 7325 | 4.300 |
1 | 1174 | 4.270 |
2 | 1435 | 4.250 |
1 | 2700 | 4.240 |
Price($) | Vol. | No. |
---|---|---|
4.420 | 5266 | 1 |
4.550 | 1000 | 1 |
4.570 | 222 | 1 |
4.580 | 6000 | 1 |
4.610 | 180 | 1 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online